Navigation Links
Medpace Opens Clinical Pharmacology Unit in Cincinnati, Ohio
Date:12/18/2007

l have a full 12-Lead Mortara Telemetry system with wireless transmission to a centralized monitoring station which can monitor and record up to thirty-two patients simultaneously which allows for thorough QTc studies. The site also has the capacity for IV infusions, Holter monitoring, and pulmonary function testing.

Amenities for the study participants will include single beds, large flat screen TVs, video games, DVD players, desktop computers, wireless internet access, an enclosed outdoor courtyard, full-service catering, and a warming kitchen for in-house meal distribution.

The Medpace CPU is unprecedented in the region for its size and state-of- the-art equipment. Its presence continues to enhance the area's growing healthcare reputation and a commitment to pharmaceutical research.

"We are pleased to offer this state-of-the-art, highly specialized Phase I and IIa facility for our clients," said August Troendle, MD, Medpace Chief Executive Officer. "We believe our therapeutic expertise in cardiovascular, oncology, and metabolic clinical trials will be a unique offering in a market place that has a high demand for Phase I and II studies but rarely specializes in a few areas of focus."

Community volunteers interested in participation may call the unit directly and speak to a recruitment specialist at: (513) 366-3222 or (859) 341-9800.

About Medpace

Medpace is a global, research-based drug development company led by top therapeutic and regulatory experts who are driven to further the advancement of pharmaceutical agents for use in cardiology, metabolism, and oncology. Medpace has assembled the industry's most experienced and therapeutically focused team to execute at every level of the company's operations, providing complete and seamless drug development services.

Through specialized regulatory expertise and therapeutically focused clinical operations, Medpace creates strategic partnerships with pharmaceutical and bi
'/>"/>

SOURCE Medpace
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
2. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
3. New Risk Gene for Rheumatoid Arthritis and Lupus Opens Door to More Effective Treatments
4. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
5. PPD Opens Offices in Sydney, Australia; Copenhagen, Denmark; Lima, Peru; and Lisbon, Portugal
6. Pilot Study Opens the Door for Avastin Use in Curative Setting for Women With Breast Cancer
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
9. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
10. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
11. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Blood America, Inc. ( www.cordblood-america.com ) (OTC Bulletin Board: ... Proxy Statement, Schedule 14A, with the U.S. Securities & Exchange ... shareholders detailing why a "YES" vote to increase the number ... As we reflect upon the 2014 fiscal year that ...
(Date:1/23/2015)... and BOSTON , January 23, 2015 ... and development company, is delighted to announce that the ... to Miles Congreve (Vice President of Chemistry), ... Malcolm Weir (Chief Executive Officer and co-founder) for the ...
(Date:1/22/2015)... DIEGO, Jan. 22, 2015  ResMed Inc. (NYSE: RMD ... 2014. Revenue for the quarter was $423.0 million, a 10 ... (a 14 percent increase on a constant currency basis). Net ... to the quarter ended December 31, 2013. Diluted earnings per ...
Breaking Medicine Technology:Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11
... Corp. / surgicalinstruments.com has developed an online ... who perform surgical instrument reprocessing for hospitals and ... pictures and descriptions of a large selection of ... rigid endoscopes, and accessories including video camera heads, ...
... Corporation ("CompCare") (OTC BB: CHCR), a leading behavioral health, ... managed care companies throughout the U.S., today announced that ... March 31, 2012 totaled $17,890,000.  Net income totaled $80,000 ... to announce that CompCare achieved a profit, albeit modest, ...
Cached Medicine Technology:Millennium Surgical Corp. Develops Online Sterilization Resource Center 2Comprehensive Care Corporation Announces Profit for First Quarter 2Comprehensive Care Corporation Announces Profit for First Quarter 3
(Date:1/22/2015)... 22, 2015 The federal court overseeing thousands ... District Court, Southern District of West Virginia has upheld a ... proceeding’s first bellwether trial. In an Order dated January 21st, ... after finding that C.R. Bard had not proven a miscarriage ...
(Date:1/22/2015)... Oceanside,CA (PRWEB) January 22, 2015 For over 20 ... the Oceanside and Vista area has treated just about ... other personal injury circumstances. And for those same twenty-plus years, ... victims of all those injuries with the best possible doctor. ...
(Date:1/22/2015)... January 23, 2015 Recently, Weddingshe.com has added ... and has announced its highest annual revenues in the past ... its popular glamorous wedding dresses. , According to the sales ... wedding dress promotions for them in 2015. This point can ...
(Date:1/22/2015)... As interest in the value of spiritual support ... Rev. Eric J. Hall , president and CEO of ... be the keynote speaker on January 27 at an international ... , The conference, “Hope and Resilience: Innovative and Interdisciplinary Spiritual ...
(Date:1/22/2015)... State Forestry Institute of Mecklenburg-Vorpommern in ... support from GEOSYSTEMS, a dedicated Hexagon Geospatial and Intergraph ... Hexagon Geospatial’s ERDAS APOLLO for cataloging, managing, ... point clouds and documents. This effort will enable the ...
Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3
... ... management organization, is pleased to announce the donation of $12,260 to the Cystic Fibrosis ... Harrisburg, ... ), a leading quality improvement and care management organization, is pleased to announce the ...
... , , , WHO: Community ... directors, nurses and other community oncology staff, WHAT: ... Technology (HIT) stimulus:, ... records (EHR), ...
... Leaders Amplifies "United We Serve" , , WASHINGTON, June ... a summer of service, U.S. Agency for International Development (USAID) ... in Baltimore for the inauguration of President Obama,s "United We ... and be a part of building a new foundation for ...
... Maximizes Biocompatibility and Biostabilityin a Bare-Metal Stent , ... announced that it has received CE mark approval for ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20070206/CLTU213LOGO ... a next-generation cobalt-chromium bare-metal stent. Utilizing a novel ion-based ...
... experience a lower rate of adverse reactions on automated 2-unit ... ZURICH, Ill., June 23 Fenwal Inc. announced today it ... M.D., Ph.D., chief medical officer of the American Red Cross, ... automated two-unit red cell procedures and manual whole blood collection ...
... BERNARDSVILLE, N.J., June 23 Protocol Driven Healthcare, Inc. ... (HRA) Data-Load Process so that organizations can merge historical ... ConXus Profile HRA. , , Organizations may be ... new vendor for fear of losing valuable health information ...
Cached Medicine News:Health News:KePRO Employees Make "Great Strides" Towards Cure for Cystic Fibrosis 2Health News:KePRO Employees Make "Great Strides" Towards Cure for Cystic Fibrosis 3Health News:US Oncology Offers Electronic Health Records Informative Webinar 2Health News:US Oncology Offers Electronic Health Records Informative Webinar 3Health News:USAID Brings White House Service Initiative to Baltimore 2Health News:USAID Brings White House Service Initiative to Baltimore 3Health News:CorNova(R) Receives CE Mark Approval for Valecor Platinum(R) Coronary Stent System 2Health News:Fenwal to Host Webinar on the Safety of 2-Unit Red Cell Collections From Young Donors 2Health News:Fenwal to Host Webinar on the Safety of 2-Unit Red Cell Collections From Young Donors 3Health News:PDHI Launches ConXus Profile Third-Party Health Risk Assessment Data-Load Process 2
The Precedent establishes a new generation of revision hip stems....
Calcar replacement stems provide options for revision and trochanteric fractures. Revision hip surgery and trauma often require prosthetic designs that replace proximal medial calcar bone loss....
...
...
Medicine Products: